February 12, 2019 Stephen Tulipano Stoneham, MA 02180Non-Competition Agreement • May 23rd, 2019 • Stoke Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 23rd, 2019 Company Industry JurisdictionOn behalf of Stoke Therapeutics, Inc. (the “Company”), this letter agreement (the “Agreement”) sets forth the terms and conditions of your appointment as the Company’s Chief Financial Officer, effective as of March 18, 2019 (the “Employment Date”).
January 7, 2018 Gene Liau, Ph.D. Wayland, MA 01778Non-Competition Agreement • May 23rd, 2019 • Stoke Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 23rd, 2019 Company Industry JurisdictionOn behalf of Stoke Therapeutics, Inc. (the “Company”), this letter agreement (the “Agreement”) sets forth the terms and conditions of your appointment as the Company’s Executive Vice President, Head of Research and Preclinical Development, effective as of January 16, 2018 (the “Employment Date”).